Background Significant trauma and muscular tightness often result during Total Knee Artroplasty (TKA) surgery and thus act to restrict tissue fluid movement resulting with lower extremity oedema.

Objective To estimate the global burden of hip and knee osteoarthritis (OA) as part of the Global Burden of Disease 2010 study and to explore how the burden of hip and knee OA compares with other ...

8 Faculty of Medicine, University of NSW, Sydney, New South Wales, Australia 9 Department of Rheumatology, St George Hospital, Sydney, New South Wales, Australia 10 Monash Department of Clinical ...

Academic Rheumatology, Clinical Sciences Building, Nottingham City Hospital, Nottingham, UK Correspondence to: Dr Edward Roddy Academic Rheumatology, Clinical Sciences Building, Nottingham City ...

Objectives To compare the use of glucocorticoids (GC) over time in patients with rheumatoid arthritis (RA) who were or were not treated initially with GC bridging therapy. Methods Data from the BeSt, ...

Objectives Juvenile idiopathic arthritis (JIA) is the most common class of childhood rheumatic diseases, with distinct disease subsets that may have diverging pathophysiological origins. Both adaptive ...

Objective Spondyloarthritis (SpA) is a chronic inflammatory disorder with high heritability but with complex genetics. Apart from HLA-B27, most of the underlying genetic components remain to be ...

2 University Hospitals Birmingham NHS Foundation Trust, Department of Rheumatology, Birmingham, United Kingdom 3 University of Birmingham, Birmingham, United Kingdom 4 NIHR Birmingham Biomedical ...

1 Faculty of Health Sciences, University of Sydney, Lidcombe, New South Wales, Australia 2 Graduate School of Medicine, Notre Dame University, Darlinghurst, New South Wales, Australia 3 Covance Pty ...

Background Vitamin D is important for bone, cartilage and muscle function but there are few studies on its association with joint pain. Objective To investigate whether serum vitamin D predicts change ...

Background Telitacicept (TACI-Fc fusion protein) is a novel BLyS (B-lymphocyte stimulator)/APRIL (a proliferation-inducing ligand) dual inhibitor, which has been approved in 2021 in China for the ...

2 Institut d'Investigació Biomèdica de Bellvitge, Hospital Universitari de Bellvitge, Departament de Reumatologia, L'Hospitalet de Llobregat, Barcelona, Spain 3 Institute for Health Metrics and ...